PhytoCare: Journal of Pharmacology and Natural Remedies
From Extract to Effect: An Evidence Synthesis of Five Selected Domains of Natural and Herbal Remedies
By Vivi Dwisiska Berutu and Rianti Sinaga.
Abstract
This paper presents a multi domain evidence synthesis examining the efficacy, safety, and mechanisms of natural and herbal remedies across five critical domains. We systematically evaluated randomized controlled trials comparing standardized versus full spectrum extracts, gut microbiota modulation of phytochemical pharmacokinetics, non CYP450 transporter mediated herb drug interactions, individualized versus fixed formula prescribing, and long term epigenetic and transcriptomic effects of adaptogens. Our methodology integrated systematic reviews, narrative synthesis, and thematic mapping across PubMed, Cochrane Library, Scopus, and Google Scholar, with data extraction capturing study design, sample size, intervention type, primary outcomes, safety signals, and mechanistic findings. The results reveal that chemically standardized extracts (e.g., ashwagandha Shoden, Rhodiola SHR 5) demonstrate reproducible signals in anxiety and stress related outcomes, yet full spectrum preparations show product specific efficacy with variable safety profiles. For gut microbiome modulation, berberine exhibited the strongest human evidence, where higher abundances of Prevotella, Bacteroides, and Megamonas correlated with lower berberine area under the curve and increased metabolite burden. Furthermore, St. John’s wort consistently reduced bioavailability of multiple P glycoprotein substrates (e.g., digoxin, cyclosporine), with hyperforin content directly correlating with interaction strength. The evidence for individualized prescribing remains limited, with only one N of 1 trial series in bronchiectasis showing modest improvements. Additionally, ashwagandha altered 19,945 genes in human neuroblastoma cells, affecting cognition and stress pathways. however, the clinical relevance of these in vitro findings remains uncertain. Overall, the available evidence suggests that selected herbal products may provide clinically relevant benefits through plausible mechanisms, but confidence in these findings varies across domains because of heterogeneity, product specificity, and methodological limitations. The synthesis supports cautious, extract-specific assessment in clinical and regulatory contexts rather than generalized claims about natural and herbal remedies.




